SI3253769T1 - Novi polimorfi - Google Patents

Novi polimorfi

Info

Publication number
SI3253769T1
SI3253769T1 SI201630228T SI201630228T SI3253769T1 SI 3253769 T1 SI3253769 T1 SI 3253769T1 SI 201630228 T SI201630228 T SI 201630228T SI 201630228 T SI201630228 T SI 201630228T SI 3253769 T1 SI3253769 T1 SI 3253769T1
Authority
SI
Slovenia
Prior art keywords
novel polymorphs
polymorphs
novel
Prior art date
Application number
SI201630228T
Other languages
English (en)
Inventor
Alexander Munro
Original Assignee
Vectura Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Limited filed Critical Vectura Limited
Publication of SI3253769T1 publication Critical patent/SI3253769T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
SI201630228T 2015-02-05 2016-01-27 Novi polimorfi SI3253769T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15153961.6A EP3053927A1 (en) 2015-02-05 2015-02-05 Novel polymorphs
PCT/EP2016/051691 WO2016124464A1 (en) 2015-02-05 2016-01-27 Novel polymorphs
EP16701774.8A EP3253769B1 (en) 2015-02-05 2016-01-27 Novel polymorphs

Publications (1)

Publication Number Publication Date
SI3253769T1 true SI3253769T1 (sl) 2019-05-31

Family

ID=52477565

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201630228T SI3253769T1 (sl) 2015-02-05 2016-01-27 Novi polimorfi

Country Status (13)

Country Link
US (2) US10087196B2 (sl)
EP (2) EP3053927A1 (sl)
JP (2) JP6685326B2 (sl)
CN (1) CN107207533B (sl)
CA (1) CA2972977C (sl)
DK (1) DK3253769T3 (sl)
ES (1) ES2722074T3 (sl)
HU (1) HUE043089T2 (sl)
PL (1) PL3253769T3 (sl)
PT (1) PT3253769T (sl)
SI (1) SI3253769T1 (sl)
TR (1) TR201905766T4 (sl)
WO (1) WO2016124464A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3727379A4 (en) * 2017-12-20 2021-12-15 Sunshine Lake Pharma Co., Ltd. PYRAZOLO [1,5-A] PYRIDINE DERIVATIVE SALTS AND THEIR USE
WO2024119058A2 (en) 2022-12-02 2024-06-06 Kinaset Therapeutics, Inc. Formulation of a pan-jak inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045595A1 (es) * 2003-09-04 2005-11-02 Vertex Pharma Composiciones utiles como inhibidores de proteinas quinasas
EP2493895B1 (en) * 2009-10-29 2017-04-26 Vectura Limited N-containing heteroaryl derivatives as jak3 kinase inhibitors
JP2011136925A (ja) * 2009-12-28 2011-07-14 Dainippon Sumitomo Pharma Co Ltd 含窒素二環性化合物

Also Published As

Publication number Publication date
US10087196B2 (en) 2018-10-02
CN107207533B (zh) 2019-04-16
EP3053927A1 (en) 2016-08-10
DK3253769T3 (da) 2019-05-27
JP6685326B2 (ja) 2020-04-22
CA2972977A1 (en) 2016-08-11
US10508123B2 (en) 2019-12-17
US20180016284A1 (en) 2018-01-18
JP2019065051A (ja) 2019-04-25
HUE043089T2 (hu) 2019-08-28
JP2018502929A (ja) 2018-02-01
ES2722074T3 (es) 2019-08-07
EP3253769A1 (en) 2017-12-13
CN107207533A (zh) 2017-09-26
US20190031687A1 (en) 2019-01-31
PL3253769T3 (pl) 2019-08-30
TR201905766T4 (tr) 2019-05-21
PT3253769T (pt) 2019-05-27
EP3253769B1 (en) 2019-03-13
WO2016124464A1 (en) 2016-08-11
CA2972977C (en) 2019-04-09

Similar Documents

Publication Publication Date Title
GB201522267D0 (en) Novel compounds
GB201521109D0 (en) Novel compounds
GB201516243D0 (en) Novel compounds
GB201522768D0 (en) Novel compounds
GB201506871D0 (en) Novel compounds
GB201506872D0 (en) Novel compounds
GB201501462D0 (en) Novel compounds
IL267530A (en) Polymorphs
IL267529A (en) polymorphs
GB201522179D0 (en) Novel compounds
GB201504565D0 (en) Novel compounds
ZA202003487B (en) Polymorphs
GB201502675D0 (en) Novel compounds
HUE043089T2 (hu) Új polimorfok
GB201403438D0 (en) Polymorphs
GB201717104D0 (en) Polymorphs
GB201622006D0 (en) Polymorphs
GB201521749D0 (en) Novel compounds
GB201521713D0 (en) Novel compounds
GB201516241D0 (en) Novel compounds
GB201512829D0 (en) Novel compounds
GB201512270D0 (en) Novel Compounds
GB201511842D0 (en) Novel compounds
GB201510191D0 (en) Novel compounds
GB201510190D0 (en) Novel compounds